Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
[forminator_form id="25163"]

Novo Nordisk on Monday announced that its blockbuster weight-loss drug semaglutide, marketed as Wegovy, helped two in five young children move below the obesity threshold in a landmark clinical trial — the first to test the GLP-1 medication in children…

HCA Healthcare announced on Monday that research published in The New England Journal of Medicine demonstrates promising results from a CRISPR gene-editing therapy tested in children ages 5 to 11 with severe sickle cell disease and transfusion-dependent beta thalassemia, marking…

Researchers at Boston Children's Hospital and Harvard used OpenAI's o3 Deep Research model to identify 18 new diagnoses among children whose rare genetic diseases had stumped clinicians for years, according to a study published Wednesday in NEJM AI.